Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2000
04/04/2000US6045815 An antifungal composition including a dipolar aprotic solvent and an aqueous secondary solvent
04/04/2000US6045809 A drug mixture consisting of prolamines and polymer films derived from prolamines with good bioavailability and therapeutic efficacy; treating inflammation
04/04/2000US6045808 Method for removing high boiling solvents from drug formulations by vacuum drying
04/04/2000US6045787 Flowing the liquid through a mixture of insoluble particles of an elemental iodine-containing material, which material acts as a sink for elemental iodine; disinfect protein containing solutions such as blood, enzymes and vaccines
04/04/2000US6045778 Stabilized medicinal aerosol solution formulations
04/04/2000US6044981 Microfabricated filter with specially constructed channel walls, and containment well and capsule constructed with such filters
04/04/2000CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins
04/04/2000CA2140053C Collagen-based injectable drug delivery system and its use
04/04/2000CA2136607C Pharmaceutical powder composition containing non-ionic cellulose ether derivative and a chitin-derived polymer
04/04/2000CA2063729C Biodegradable system for regenerating the periodontium
04/04/2000CA2013899C Density element and method of manufacture thereof
04/04/2000CA2006975C Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
04/01/2000CA2284387A1 Use of peptide preventing skin intolerance reactions, notably in cosmetic compounds
03/2000
03/30/2000WO2000017294A1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin
03/30/2000WO2000016848A1 Systems and methods for treating ischemia
03/30/2000WO2000016818A1 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same
03/30/2000WO2000016814A1 Medicinal aerosol formulation
03/30/2000WO2000016793A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
03/30/2000WO2000016784A1 Oral drug delivery system for enhancing the bioavailability of activated glycyrrhetin
03/30/2000WO2000016779A1 Antiviral combinations comprising lamivudine and abacavir
03/30/2000WO2000016776A1 Sustained release oral preparations
03/30/2000WO2000016775A1 Topical formulation of alkyl-, phenyl-pyridone
03/30/2000WO2000016774A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparations containing pyridonecarboxylic acid and process for producing the same
03/30/2000WO2000016762A2 Method for reducing nicotine dependency
03/30/2000WO2000016752A2 Transdermal devices comprising essential oils for aromatherapy
03/30/2000WO2000016751A1 Fentanyl composition for the treatment of acute pain
03/30/2000WO2000016750A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000WO2000016749A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
03/30/2000WO2000016748A1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
03/30/2000WO2000016747A1 Agitation-independent pharmaceutical multiple unit retard preparations and method for the production thereof
03/30/2000WO2000016746A2 Immunogenic liposome compositions
03/30/2000WO2000016745A2 Micronised pharmaceutical compositions
03/30/2000WO2000016744A1 A pharmaceutical solution for the treatment of erectile dysfunction, prepared by sedds formulation
03/30/2000WO2000016743A1 Semi-moist oral delivery system
03/30/2000WO2000016742A1 Chewable compositions containing dextromethorphan
03/30/2000WO2000016741A1 Method and system for enhancing delivery of an agent
03/30/2000WO2000016739A1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling
03/30/2000WO2000016736A1 Oral care compositions
03/30/2000WO2000009096B1 Injectable formulations of nanoparticulate naproxen
03/30/2000WO2000003680A3 Emollient esters based upon capryl alcohol and isostearic acid
03/30/2000WO2000002601A3 Transdermal delivery system
03/30/2000WO2000000186A8 Method of treating topical ailments
03/30/2000WO2000000120A9 Methods and transdermal compositions for pain relief
03/30/2000WO1999067212A3 Active carbon filter as an oxidation inhibitor for prostane derivatives
03/30/2000WO1999049892A3 Use of active p40 conjugates for nasal delivery
03/30/2000WO1999040932A9 Mixed micellar pharmaceutical delivery system and method of preparation
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19843904A1 Solid dosage form for prolonged slow release of e.g. drugs, plant treatment agents, or food or feed additives, containing copolymer of N-vinyl-lactam, methyl methacrylate and further monomer(s) as binder
03/30/2000DE19843903A1 Solid dosage form for prolonged slow release of e.g. drugs, plant treatment agents or food or feed additives, containing copolymer of N-vinyl-lactam and methyl methacrylate as binder
03/30/2000CA2820588A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000CA2629988A1 Pharmaceutical composition for the treatment of acute disorders
03/30/2000CA2354037A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
03/30/2000CA2344396A1 Transdermal devices comprising essential oils for aromatherapy
03/30/2000CA2344306A1 Oral drug delivery system for enhancing the bioavailability of active form of glycyrrhizin
03/30/2000CA2344215A1 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same
03/30/2000CA2342976A1 Oral care compositions
03/30/2000CA2342742A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
03/30/2000CA2342732A1 Water-soluble concentrate obtained for an emulgator or water-solubilising phase and a complex of liquid lipophile substances of plant origin
03/30/2000CA2310433A1 Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparation containing pyridonecarboxylic acid and production method thereof
03/29/2000EP0988863A2 Stable complexes of poorly soluble compounds
03/29/2000EP0988861A1 Stabilized protein compositions
03/29/2000EP0988859A1 Active substance preparations and a process for producing the same
03/29/2000EP0988858A1 Microemulsion
03/29/2000EP0988857A1 Nutrient infusion preparation
03/29/2000EP0988852A2 Cool feeling composition
03/29/2000EP0988838A2 Substance delivery device
03/29/2000EP0988542A1 A method and an industrial process for determining dose-level characteristics of a multiple unit system
03/29/2000EP0988374A1 Hydrophilic composition containing protease produced by vibrio
03/29/2000EP0988324A1 Method for manufacturing pure guar meal
03/29/2000EP0988106A1 Method for producing small-particle preparations of biologically active substances
03/29/2000EP0988061A1 Methods for delivering bioactive agents
03/29/2000EP0988055A1 Compositions comprising flexible particles, non-ionic surfactant and non-ionic cloud-point modifier
03/29/2000EP0988052A2 An influenza enveloped dna vaccine
03/29/2000EP0988046A1 Oil-free pharmaceutical compositions containing cyclosporin a
03/29/2000EP0988033A1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol
03/29/2000EP0988032A1 IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
03/29/2000EP0988031A1 Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
03/29/2000EP0988030A1 Knobby nanospheres
03/29/2000EP0988029A1 Device and methods for wound treatment
03/29/2000EP0988028A1 Therapeutically active compositions
03/29/2000EP0988009A1 Device and method for treatment of dysmenorrhea
03/29/2000EP0988007A1 Intravaginal drug delivery system and discharge collection device
03/29/2000EP0987954A1 A spinner head having flow restricting inserts
03/29/2000EP0987942A1 Pharmaceutical composition and methods for using it
03/29/2000EP0801554A4 Formulations and methods for reducing skin irritation
03/29/2000EP0735868B1 Use of non-steroidal cyclooxygenase inhibitors for the manufacture of a medicament for the treatment of elevated intraocular pressure
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000EP0620733B1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof
03/29/2000CN2370868Y Multi-layer structure plaster
03/29/2000CN1248914A Pharmaceutical composition
03/29/2000CN1248913A Pharmaceutical composition for programmed release of dexfenfluramine
03/29/2000CN1248911A Opthalmic non-irritating iodine medicament and method
03/29/2000CN1248904A Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin
03/29/2000CN1248468A Traditional Chinese medicine Sanfeng anti-cancer capsule for curing lung cancer and preparation process thereof
03/29/2000CN1248465A Method for producing Anruneixiao medicinal liquid
03/29/2000CN1248463A Xiancaoyangyan cream and preparation process thereof
03/29/2000CN1248458A Method for preparing Fuyankan suppository (gynopathy medicine)
03/29/2000CN1248454A Jingtongtie plaster for treating cervicodynia and preparation process
03/29/2000CN1248451A Shenmei soft and hard capsule
03/29/2000CN1248448A Scorption and ant health care liquor
1 ... 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 ... 2991